You are required to be logged in to access the full website
Click here if you have forgotten your username or password
20 November 2026 - Biotechnology company BioMimetix JV LLC announced on Thursday the publication of results from a multicentre Phase I/II clinical trial evaluating BMX-001, a redox-active metalloporphyrin compound, in patients undergoing chemoradiati...
20 November 2026 - Luminopia Inc, a digital health company developing a new class of treatments for neuro-visual disorders, announced on Thursday that it has been named a Winner at the 2026 Digital Health Hub – Digital Health & AI Awards, p...
20 November 2026 - Kibow Biotech, a developer of probiotic dietary supplements for kidney health, announced on Thursday the availability of its flagship product, Renadyl, in Canada.Developed through decades of research into the relationship between g...
20 November 2026 - Interlude Biopharma Co, a late-stage, drug-development company focused on celiac disease, announced on Thursday the company's public launch at the 21st International Celiac Disease Symposium (ICDS 2026) and introduced plans fo...
19 November 2026 - China-based biopharmaceutical company Innogen Pharmaceuticals (HKEX: 2591) said on Thursday it has signed an exclusive licensing and commercialisation agreement with Arcera Life Sciences for its internally developed GLP-1 therapy, ...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe